All rBIO articles

  • Cameron_Owen
    Article

    Next-gen biotech: rBIO’s approach to affordable insulin solutions

    2025-04-04T09:00:20Z

    rBIO is transforming the biosimilar insulin market with a novel biomanufacturing platform designed to reduce production costs while maintaining high-quality standards. CEO Cameron Owen shares how their approach is shaping drug discovery and improving patient access to life-saving treatments.